Hawaii hemp laws lawsuit is reshaping how small retailers sell hemp products statewide. Because the state now uses total THC limits, many items face uncertain legal status. However, recent court challenges raise questions about due process and commerce.
In this article we explain what the Hawaii Department of Health rules mean for store owners and online sellers, we outline the legal claims made by O‘ahu Dispensary and Provisions founder Lance Alyas and his argument that state rules conflict with the 2018 Farm Bill, we describe how federal changes scheduled for November 12 could further narrow the legal definition of hemp, and we offer practical steps retailers can take now to reduce risk, because clear compliance strategies and careful testing can protect businesses from fines, registration suspensions and product seizures while broader court rulings and legislative fixes play out and help owners plan inventory and marketing through uncertain enforcement timelines effectively.
What is the Hawaii hemp laws lawsuit?
The Hawaii hemp laws lawsuit challenges state Department of Health rules. However, the rules define hemp by total THC, not federal delta-9 thresholds. Plaintiff Lance Alyas says the change criminalizes many formerly legal products and harms interstate commerce. The suit also alleges due process violations and therefore seeks clarity for retailers.
Background of the Hawaii Hemp Laws Lawsuit
The Hawaii hemp laws lawsuit began when O‘ahu Dispensary and Provisions founder Lance Alyas filed a federal complaint in August 2025. The suit challenges recent state rules that change how hemp is defined. Because Alyas says those rules made roughly 80 percent of his inventory illegal, he seeks court relief. For initial reporting on the complaint see the federal lawsuit against Hawaii hemp regulations: federal lawsuit targets state hemp regulations.
At the core are two legal issues. First, Hawaii’s Department of Health defines hemp by total THC, not by delta-9 thresholds in the 2018 Farm Bill. Second, the complaint alleges the rules place an undue burden on interstate commerce and violate due process. State officials including the Attorney General and DOH Director have moved to dismiss the case. For official rules and definitions consult Hawai‘i hemp interim rules and statutes.
The lawsuit already affects the Hawaii hemp industry. Retailers face new registration requirements, stricter testing, and the risk of fines and product seizures. As a result many stores paused sales of popular hemp-derived items. Moreover, business owners report enforcement sting operations and sudden inventory losses. Therefore retailers and legal observers now watch the case closely for long-term clarity on hemp regulations in Hawaii.

Current Hemp Laws & Regulations in Hawaii
Hawaii hemp laws lawsuit and state definitions
Hawaii now defines hemp based on total tetrahydrocannabinol rather than only delta-9 THC. As a result the state standard can differ from the 2018 Farm Bill and create legal friction. Federal changes to the statutory hemp definition are also pending and could affect this conflict; see the enacted federal language for details: enacted federal language.
Farming, processing and retail rules in Hawaii
The Hawaii Department of Health regulates hemp farming, processing and the sale of manufactured hemp products. In practice this means tighter testing, new labeling rules and a registration requirement for distributors and retailers. Moreover the Office of Medical Cannabis Control and Regulation oversees manufactured hemp products and retail certificates. For current program guidance and registration forms see the state hemp program page: state hemp program page.
Key regulations summary
- Registered vendors must obtain an OMCCR certificate to sell manufactured hemp products in Hawaii.
- Hawaii uses a total THC calculation when testing hemp products, not a delta-9-only test.
- Retailers must register beginning in 2026 and face enforcement actions after registration deadlines.
- Vendors can be fined up to $10,000 per offense for selling noncompliant products.
- The DOH may suspend registrations and authorize destruction or seizure of noncompliant inventory.
- Processors and manufacturers must meet packaging, labeling and testing standards set by the DOH.
Taken together these rules change compliance burdens for the Hawaii hemp industry. Therefore retailers and processors should confirm testing methods, maintain product records, and track registration timelines to reduce enforcement risk.
Comparison of Hemp Laws Pre- and Post-Lawsuit
| Category | Before the Lawsuit | After the Lawsuit and Rule Changes |
|---|---|---|
| Licensing requirements | No statewide OMCCR distributor registration in effect. Many retailers operated under federal hemp rules. | New law requires all hemp distributors to register with DOH OMCCR starting 2026. Retailers must obtain registration to sell manufactured hemp products. |
| THC limits and definitions | State law originally aligned with the 2018 Farm Bill. Hemp allowed if delta-9 THC was 0.3% or less by dry weight. | Hawaii DOH adopted a total THC concentration test. This differs from the delta-9 0.3% standard and creates legal conflict with federal definitions. |
| Business impact | Broad product availability and active interstate sales under federal standards. Retailers stocked many hemp-derived items. | Plaintiff says about 80 percent of prior inventory became effectively illegal. Many stores paused sales and face higher compliance costs. |
| Enforcement policies | Enforcement generally followed federal guidance with fewer seizures for compliant hemp. | DOH can fine vendors up to $10,000 per offense, suspend registrations, and authorize seizure or destruction of noncompliant products. Reports of sting operations were alleged by the plaintiff. |
Implications and Future Outlook of the Hawaii Hemp Laws Lawsuit
The Hawaii hemp laws lawsuit raises immediate hemp business risks for retailers and processors. Because the state enforces a total THC standard, many products face removal from shelves. Therefore businesses must reassess inventory, testing protocols, and supplier contracts to avoid fines and seizures.
Consumers may see reduced product choice and higher prices in the hemp market Hawaii. Moreover vulnerable customers who rely on specific hemp formulations could lose access. As a result public demand may push lawmakers to revisit definitions and testing rules.
Lawmakers and regulators now face several paths forward. They can defend strict DOH rules, amend state law to match federal thresholds, or seek clarity from the federal courts. For context on pending federal changes that affect hemp definitions see the enacted federal law text: federal law text. Also consult Hawaii DOH guidance for current registration and program details: Hawaii DOH guidance.
Looking ahead plaintiffs may obtain injunctive relief, or courts could dismiss the case. However, the November federal rule changes will likely shift market dynamics. Therefore hemp businesses should prepare for evolving regulation, seek legal counsel, and document compliance closely to reduce risk. In short, expect legal uncertainty to persist, but plan operationally to protect customers and assets.
CONCLUSION
The Hawaii hemp laws lawsuit highlights a real conflict between state rules and federal hemp standards. Because Hawaii uses a total THC test, many products now face unclear legal status. As a result retailers, processors and consumers face immediate compliance and access challenges.
Therefore businesses should tighten testing, document supply chains, and consult legal counsel. Meanwhile consumers should expect reduced selection and possible price increases. Lawmakers may revise rules or the courts may resolve the dispute.
Stay informed and prepare operationally to reduce hemp business risks in Hawaii. We will monitor developments and report major rulings promptly. For ongoing updates and practical guides visit My CBD Advisor.
Frequently Asked Questions (FAQs)
What is the Hawaii hemp laws lawsuit?
The Hawaii hemp laws lawsuit is a federal challenge filed by O‘ahu Dispensary and Provisions founder Lance Alyas against Hawaii Department of Health rules. It argues the state’s total THC definition conflicts with federal standards. The suit also alleges due process violations and burdens on interstate commerce. The case seeks injunctive relief and declaratory judgment.
Who are the parties and main legal claims?
The plaintiff is Lance Alyas and O‘ahu Dispensary and Provisions, LLC. The defendants include the State of Hawaii, Attorney General Anne Lopez, and DOH Director Kenneth Fink. The claims focus on conflict with the 2018 Farm Bill, improper seizure of property, and commerce clause concerns. The state has moved to dismiss the suit.
How does the lawsuit affect hemp retailers and the hemp market Hawaii?
Retailers face product removals, stricter testing, and registration deadlines. As a result, many paused sales and reassessed suppliers. Therefore the hemp market Hawaii may see reduced choices and higher prices. Smaller shops face the largest hemp business risks. Consumers should ask questions before buying.
Could federal rule changes or court decisions resolve this conflict?
Yes, courts could issue an injunction or dismiss the case. However, new federal rules taking effect November 12 will also change the legal landscape. Consequently businesses should track both court filings and federal updates. Regulatory timelines and legal rulings will interact. Subscribe to legal alerts covering hemp law.
What should retailers do now to reduce hemp business risks?
First, verify product test reports and confirm total THC calculations. Second, register with DOH OMCCR when required and keep compliance records. Finally, consult specialized legal counsel and update supplier contracts to limit exposure. Also notify insurers and document all compliance steps. Prepare contingency plans for inventory and cash flow.
Related on CBD Advisor
- Why the Missouri ban on intoxicating hemp products matters
- CMS-guidance for hemp products in select federal health programs
- Missouri ban on intoxicating hemp products (hemp-derived THC) consequences









